Table 4.
Comparison of GABRG2 Rs211037 Genotype Distribution in Children with Epilepsy with or without VPA-Induced dADRs
| Genetic Model | Genotype | Children with Epilepsy with dADRs(n=35) | Children with Epilepsy without dADRs (n=61) | P value | OR (95% CI) |
|---|---|---|---|---|---|
| Allele contrast | C vs T | 36 (51.0%)/ | 43 (35.0%) / | 0.028* | 1.00 |
| 34 (49.0%) | 79 (65.0%) | 1.95 (1.07–3.60) | |||
| Codominant | CC vs CT vs TT | 10 (28.6%) / | 6 (9.8%) / | 0.054 | 1.00 |
| 16 (45.7%) / | 31 (50.8%) / | 1.38 (0.52–3.65) | |||
| 9 (25.7%) | 24 (39.3%) | 4.44 (1.25–15.82) | |||
| Dominant | CT + CC vs.TT | 26 (74.3%)/ | 37 (60.7%)/ | 0.17 | 1.00 |
| 9 (25.7%) | 24 (39.3%) | 1.87 (0.75–4.68) | |||
| Recessive | CC vs CT+TT | 10 (28.6%) / | 6 (9.8%)/ | 0.037* | 1.00 |
| 25 (71.4%) | 55 (90.1%) | 3.67 (1.23–11.66) | |||
| Overdominant | CC + TT vs CT | 19 (54.3%)/ | 30 (49.1%)/ | 0.63 | 1.00 |
| 16 (45.7%) | 31 (50.8%) | 0.81 (0.35–1.87) | |||
| Log-additive | CC vs TT | 10 (28.6%) / | 6 (9.8%) / | 0.027* | 1.00 |
| 9 (25.7%) | 24 (39.3%) | 4.44 (1.33–13.72) |
Note: * P< 0.05.